559 related articles for article (PubMed ID: 17682824)
1. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
[TBL] [Abstract][Full Text] [Related]
2. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
Murthy VH; Krumholz HM; Gross CP
JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
[TBL] [Abstract][Full Text] [Related]
3. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.
Sateren WB; Trimble EL; Abrams J; Brawley O; Breen N; Ford L; McCabe M; Kaplan R; Smith M; Ungerleider R; Christian MC
J Clin Oncol; 2002 Apr; 20(8):2109-17. PubMed ID: 11956272
[TBL] [Abstract][Full Text] [Related]
4. Racial and ethnic disparities in cancer survival by neighborhood socioeconomic status in Surveillance, Epidemiology, and End Results (SEER) Registries.
Kish JK; Yu M; Percy-Laurry A; Altekruse SF
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):236-43. PubMed ID: 25417237
[TBL] [Abstract][Full Text] [Related]
5. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials.
Tejeda HA; Green SB; Trimble EL; Ford L; High JL; Ungerleider RS; Friedman MA; Brawley OW
J Natl Cancer Inst; 1996 Jun; 88(12):812-6. PubMed ID: 8637047
[TBL] [Abstract][Full Text] [Related]
6. Racial and Ethnic Disparities in Clinical Trial Enrollment Among Women With Gynecologic Cancer.
Khadraoui W; Meade CE; Backes FJ; Felix AS
JAMA Netw Open; 2023 Dec; 6(12):e2346494. PubMed ID: 38060227
[TBL] [Abstract][Full Text] [Related]
7. Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participation.
Nooka AK; Behera M; Lonial S; Dixon MD; Ramalingam SS; Pentz RD
Cancer; 2016 Oct; 122(20):3207-3214. PubMed ID: 27404488
[TBL] [Abstract][Full Text] [Related]
8. A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group.
Newman LA; Hurd T; Leitch M; Kuerer HM; Diehl K; Lucci A; Giuliano A; Hunt KK; Putnam W; Wells SA
J Am Coll Surg; 2004 Oct; 199(4):644-51. PubMed ID: 15454152
[TBL] [Abstract][Full Text] [Related]
9. Race-ethnicity and gender differences in VA health care service utilization among U.S. veterans of recent conflicts.
Koo KH; Madden E; Maguen S
Psychiatr Serv; 2015 May; 66(5):507-13. PubMed ID: 25588415
[TBL] [Abstract][Full Text] [Related]
10. National cancer clinical trials: children have equal access; adolescents do not.
Bleyer WA; Tejeda H; Murphy SB; Robison LL; Ross JA; Pollock BH; Severson RK; Brawley OW; Smith MA; Ungerleider RS
J Adolesc Health; 1997 Dec; 21(6):366-73. PubMed ID: 9401854
[TBL] [Abstract][Full Text] [Related]
11. Racial Disparities in Hypofractionated Radiotherapy Breast Cancer Clinical Trials.
Housri N; Khan AJ; Taunk N; Goyal S; Nelson CJ; Ferro A; Haffty BG
Breast J; 2015; 21(4):387-94. PubMed ID: 25919123
[TBL] [Abstract][Full Text] [Related]
12. Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies.
Aldrighetti CM; Niemierko A; Van Allen E; Willers H; Kamran SC
JAMA Netw Open; 2021 Nov; 4(11):e2133205. PubMed ID: 34748007
[TBL] [Abstract][Full Text] [Related]
13. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
14. Sociodemographic analysis of patients in radiation therapy oncology group clinical trials.
Chamberlain RM; Winter KA; Vijayakumar S; Porter AT; Roach M; Streeter O; Cox JD; Bondy ML
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):9-15. PubMed ID: 9422552
[TBL] [Abstract][Full Text] [Related]
15. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
16. Variation in Accrual and Race/Ethnicity Reporting in Urological and Nonurological Related Cancer Trials.
Paul K; Sathianathen N; Dahm P; Le C; Konety BR
J Urol; 2019 Aug; 202(2):385-391. PubMed ID: 31074679
[TBL] [Abstract][Full Text] [Related]
17. Participation of racial/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999.
Evelyn B; Toigo T; Banks D; Pohl D; Gray K; Robins B; Ernat J
J Natl Med Assoc; 2001 Dec; 93(12 Suppl):18S-24S. PubMed ID: 11798060
[TBL] [Abstract][Full Text] [Related]
18. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older.
Li CI; Malone KE; Daling JR
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):601-7. PubMed ID: 12101106
[TBL] [Abstract][Full Text] [Related]
19. Equal participation of minority patients in U.S. national pediatric cancer clinical trials.
Bleyer WA; Tejeda HA; Murphy SB; Brawley OW; Smith MA; Ungerleider RS
J Pediatr Hematol Oncol; 1997; 19(5):423-7. PubMed ID: 9329463
[TBL] [Abstract][Full Text] [Related]
20. Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years.
Duma N; Vera Aguilera J; Paludo J; Haddox CL; Gonzalez Velez M; Wang Y; Leventakos K; Hubbard JM; Mansfield AS; Go RS; Adjei AA
J Oncol Pract; 2018 Jan; 14(1):e1-e10. PubMed ID: 29099678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
